Keyphrases
Multiple Sclerosis
100%
Multiple Sclerosis Treatment
39%
Expanded Disability Status Scale
14%
COVID-19
14%
Physical Activity
13%
Disease Duration
12%
Pediatric multiple Sclerosis
11%
Cognitive Performance
11%
Disability
11%
Disease-modifying Therapy
10%
Humoral Immune Response
10%
Epilepsy
10%
Relapsing-remitting multiple Sclerosis
9%
Gait Variability
9%
COVID-19 Vaccination
8%
Fear of Falling
7%
Gait
7%
Disease Progression
6%
Israeli
6%
Walking Speed
6%
Cognitive Impairment
6%
Memory T Cells
6%
Memory B Cells
6%
Disability Progression
6%
Leisure-time Physical Activity
6%
Intravenous Immunoglobulin (IVIg)
6%
Structural Magnetic Resonance Imaging (sMRI)
6%
GRIN2A
6%
Medical Cannabis
6%
Cognitive Function
6%
Gait Characteristics
6%
Pediatric
6%
Executive Function
6%
Seizure
5%
Insufficiently Active
5%
Severe Disabilities
5%
Fingolimod
5%
Older Adults
5%
Landau-Kleffner Syndrome
5%
Immune Response
5%
Vaccine Dose
5%
Medicine and Dentistry
Multiple Sclerosis
39%
Epileptic Seizure
15%
Pediatrics
11%
COVID-19
10%
Disease
8%
Immunoglobulin
6%
Intractable Epilepsy
6%
Convalescence
6%
Disease Modifying Therapy
6%
Medical Cannabis
6%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Drug Resistant Epilepsy
5%
Memory B Cell
5%
